Teva Gets Investment From Royalty On Olanzapine LAI

Follows Successful Launch Of Uzedy LAI Risperidone In The US Earlier This Year

Dollar sign wearing crown with gold background
Teva has garnered investment from Royalty in olanzapine LAI • Source: Shutterstock

More from Deals

More from Business